Literature DB >> 36161090

Nail Changes in People Living with Human Immunodeficiency Virus: Observational and Cross-Sectional Study in a Third-Level Hospital.

Luis R Flores-Bozo1, Silvia Méndez-Flores1, Valeria Olvera-Rodríguez1, Josune Echevarría-Keel1, Lilly Esquivel-Pedraza1, Andrea Rangel-Cordero2, Pablo F Belaunzarán-Zamudio2, Judith G Domínguez-Cherit1.   

Abstract

Introduction: Nail changes in people living with human immunodeficiency virus (HIV) have been scarcely reported. The aim of this study was to establish the frequency and characteristics of nail alterations observed in adults with HIV infection in a third-level hospital in Mexico. Method: Observational and cross-sectional study carried out in 205 patients receiving care at the HIV/AIDS Clinic of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) in Mexico City. We performed a nail and iconographic assessment of both hands and toenails. We collected information of demographic and clinical variables, as well as drugs use, and antiretroviral treatment used by the participants through a questionnaire and from medical records. We performed direct cytological examinations and nail mycological cultures in participants with symptoms of onychomycosis.
Results: The participants were predominantly male patients (91.2%), with a mean age of 41 (range 21-78) years, under antiretroviral therapy (91.2%), with a suppressed viral load (78.5%) and mean CD4+ lymphocyte count of 379.5 (range 20-1,162) cells/μL. Fitzpatrick's IV phototype was prevailing in the studied population (70%). Nail changes were documented in 72.2% of the patients; being pigmentary changes (37.1%) and trauma (30.7%) the most frequent. Onychomycosis was observed in 26.3%; with total dystrophic onychomycosis as the most frequent clinical variant (68.5%). We obtained fungal isolates in 59.3% of participants and Candida parapsilosis was the most frequent of these (37.5%). Conclusions: We observed a high prevalence of nail changes with very diverse etiology, as well as a variety of nondermatophytic yeasts and molds isolates associated with cases with onychomycosis. These findings reinforce and confirm the need for routine nail examination and stress the importance of medical personnel working with people living with HIV to have broad knowledge of nail pathology.
Copyright © 2022 by S. Karger AG, Basel.

Entities:  

Keywords:  Human immunodeficiency virus; Nail; Nail disorder; Nail fungus; Onychomycosis

Year:  2022        PMID: 36161090      PMCID: PMC9485993          DOI: 10.1159/000524257

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  29 in total

1.  Onychomycosis caused by Scytalidium dimidiatum.

Authors:  B E Elewski
Journal:  J Am Acad Dermatol       Date:  1996-08       Impact factor: 11.527

2.  [Clinical and mycological evaluation of onychomycosis among Brazilian HIV/AIDS patients].

Authors:  Idalina Inês Fonsêca Nogueira Cambuim; Danielle Patrícia Cerqueira Macêdo; Marília Delgado; Kedma de Magalhães Lima; Genilda Pereira Mendes; Cristina Maria de Souza-Motta; Débora Maria Massa Lima; Maria José Fernandes; Oliane Maria Correia Magalhães; Lusinete Acioli de Queiroz; Rejane Pereira Neves
Journal:  Rev Soc Bras Med Trop       Date:  2011 Jan-Feb       Impact factor: 1.581

3.  Quantitative evaluation of the antifungal properties of cycloheximide.

Authors:  I F Salkin; N Hurd
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

Review 4.  Skin typing: Fitzpatrick grading and others.

Authors:  Vishal Gupta; Vinod Kumar Sharma
Journal:  Clin Dermatol       Date:  2019-07-17       Impact factor: 3.541

5.  Improvement in onychomycosis after initiation of combined antiretroviral therapy.

Authors:  Gabriela Moreno-Coutiño; Roberto Arenas; Gustavo Reyes-Terán
Journal:  Int J Dermatol       Date:  2012-09-24       Impact factor: 2.736

6.  Virulence properties and sensitivity profile of Candida parapsilosis complex species and Kodamaea ohmeri isolates from onychomycosis of HIV/AIDS patients.

Authors:  Erika Oliveira Ferreira; Iven Neylla Vale Farias Mendes; Sílvio Gomes Monteiro; Karla Tonelli Bicalho Crosara; Walter Luiz Siqueira; Conceição de Maria Pedroso Silva de Azevedo; Eduardo Buozi Moffa; Cristina de Andrade Monteiro
Journal:  Microb Pathog       Date:  2019-05-11       Impact factor: 3.738

7.  A clinical and mycological study of onychomycosis in HIV infection.

Authors:  Amar Surjushe; Ratnakar Kamath; Chetan Oberai; Dattatray Saple; Minal Thakre; Sujata Dharmshale; Aruna Gohil
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Nov-Dec       Impact factor: 2.545

8.  Prevalence and etiology of onychomycosis in the HIV-infected Mexican population.

Authors:  Carmen Jimenez-Gonzalez; José Antonio Mata-Marin; Carla Ileana Arroyo-Anduiza; Iván de Jesús Ascencio-Montiel; José Luis Fuentes-Allen; Jesús Gaytan-Martinez
Journal:  Eur J Dermatol       Date:  2013 May-Jun       Impact factor: 3.328

Review 9.  Onychomycosis: Which fungal species are involved? Experience of the Laboratory of Parasitology-Mycology of the Rabta Hospital of Tunis.

Authors:  A Ben Youssef; A Kallel; Z Azaiz; S Jemel; N Bada; A Chouchen; N Belhadj-Salah; N Fakhfakh; S Belhadj; K Kallel
Journal:  J Mycol Med       Date:  2018-08-11       Impact factor: 2.391

10.  Subclinical Onychomycosis: Not Present in HIV-Positive Population?

Authors:  Claudia Contreras-Rivera; Sonia Toussaint-Caire; Ramón Fernández-Martínez; Gabriela Moreno-Coutiño
Journal:  Skin Appendage Disord       Date:  2018-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.